FDA Inspection 842005 — Allergan Sales, LLC

Allergan Sales, LLC — FEI 1643525

The FDA completed an inspection of Allergan Sales, LLC on Aug 2, 2013 in Waco, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 2, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Waco, TX (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
116221 CFR 211.28(a)Protective Apparel Not Worn
117721 CFR 211.63Equipment Design, Size and Location
188321 CFR 211.165(a)Testing and release for distribution
202721 CFR 211.192Investigations of discrepancies, failures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.